13F-HR filed by QVT Financial LP
QVT Financial LP filed this 13F-HR for the quarter ended 2016-09-30, filed 2016-11-14, with 71 holding rows worth $2,652,691,000.
- Accession
- 0000950123-16-022293
- Filer
- CIK 1290162
- Filed
- 2016-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2016
A holdings report, 71 entries on the cover page, a total value of $2,652,691,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,652,691,000 with VALUE read as thousands by filing date, 13F file number 028-11172. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AXOVANT SCIENCES LTD | G0750W104 | COM | 75,000,000 | $1,050,000,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 4,781,800 | $316,986,000 | thousands by filing date | put |
| MICROCHIP TECHNOLOGY INC | 595017AB0 | SDCV 2.125%12/1 | 31,764,000 | $82,376,000 | thousands by filing date | principal |
| VERISIGN INC | 92343EAD4 | CORPORATE OBLIG | 34,600,000 | $79,419,000 | thousands by filing date | principal |
| TAL ED GROUP | 874080AB0 | NOTE 2.500 5/1 | 29,000,000 | $78,913,000 | thousands by filing date | principal |
| Goldman Sachs Group,Inc. | 38141G104 | COM | 427,558 | $68,952,000 | thousands by filing date | |
| NOVELLUS SYS INC | 670008AD3 | NOTE 2.625% 5/1 | 20,193,000 | $56,518,000 | thousands by filing date | principal |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 16,013,540 | $55,087,000 | thousands by filing date | |
| SHIP FINANCE INTERNATIONAL L | G81075AE6 | NOTE 3.250% 2/0 | 40,500,000 | $43,674,000 | thousands by filing date | principal |
| MAKEMYTRIP LIMITED MAURITIUS SHS | V5633W109 | Stock | 1,794,024 | $39,612,000 | thousands by filing date | |
| Intel Corp | 458140100 | COM | 930,004 | $35,108,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464AB6 | NOTE 2.500% 9/1 | 36,295,000 | $34,670,000 | thousands by filing date | principal |
| ANTHEM INC | 94973VBG1 | NOTE 2.750%10/1 | 18,500,000 | $32,718,000 | thousands by filing date | principal |
| CTRIP COM INTL LTD | 22943FAD2 | NOTE 1.250%10/1 | 25,000,000 | $32,437,000 | thousands by filing date | principal |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 496,434 | $30,486,000 | thousands by filing date | |
| ISHARES TR | 464287556 | ISHARES BIOTECH | 93,730 | $27,131,000 | thousands by filing date | |
| NORTHSTAR REALTY EUROPE CORP | 66706L101 | COM | 2,314,090 | $25,339,000 | thousands by filing date | |
| NEW YORK TIMES CO MTN BE CL A | 650111107 | Stock | 1,949,409 | $23,295,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 3,218,707 | $23,110,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 636,764 | $23,044,000 | thousands by filing date | |
| INTEL CORP | 458140AD2 | SDCV 2.950%12/1 | 15,500,000 | $21,557,000 | thousands by filing date | principal |
| COTERRA ENERGY INC COM | 127097103 | Stock | 824,742 | $21,278,000 | thousands by filing date | |
| EQUITY COMMONWEALTH | 294628102 | COM SH BEN INT | 680,000 | $20,550,000 | thousands by filing date | |
| AMBARELLA INC | G037AX101 | SHS | 275,877 | $20,307,000 | thousands by filing date | |
| IKANG HEALTHCARE GROUP INC | 45174L108 | SPONSORED ADR | 1,118,340 | $20,225,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 2,556,256 | $18,788,000 | thousands by filing date | |
| PDVWIRELESS INC | 69290R104 | COM | 902,599 | $18,466,000 | thousands by filing date | |
| NORDIC AMERICAN TANKERS LIMI | G65773106 | COM | 1,757,500 | $17,768,000 | thousands by filing date | put |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 676,765 | $15,335,000 | thousands by filing date | |
| DHT HOLDINGS INC | 23335SAB2 | DEBT 4.50010/0 | 17,000,000 | $15,172,000 | thousands by filing date | principal |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 91,881 | $15,123,000 | thousands by filing date | |
| MARVELL TECHNOLOGY GROUP LTD | G5876H105 | ORD | 1,139,262 | $15,118,000 | thousands by filing date | |
| Lion Biotechnologies | 53619R102 | COM | 1,751,509 | $14,335,000 | thousands by filing date | |
| CTRIP COM INTL LTD | 22943FAF7 | NOTE 1.000% 7/0 | 13,000,000 | $14,166,000 | thousands by filing date | principal |
| PAYPALHLDGSINC | 70450Y103 | STOK | 344,190 | $14,101,000 | thousands by filing date | |
| XILINX INC | 983919101 | COM | 236,855 | $12,871,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 133,933 | $12,391,000 | thousands by filing date | |
| TAIWAN SEMICONDUCTOR MFG | 874039100 | SPONSORED ADS | 400,000 | $12,236,000 | thousands by filing date | put |
| WEBMD HEALTH CORP | 94770VAF9 | NOTE 2.500% 1/3 | 11,000,000 | $11,490,000 | thousands by filing date | principal |
| Wells Fargo & Company | 949746101 | COM | 255,000 | $11,291,000 | thousands by filing date | |
| BRF SA | 10552T107 | SPONSORED ADR | 607,112 | $10,357,000 | thousands by filing date | |
| YY INC. ADR | 98426T106 | SPONSORED ADS A | 190,700 | $10,160,000 | thousands by filing date | |
| ANTERO RESOURCES CORP COM | 03674X106 | Stock | 373,413 | $10,063,000 | thousands by filing date | |
| AVEXIS INC | 05366U100 | COM | 224,756 | $9,262,000 | thousands by filing date | |
| TEEKAY TANKERS LTD | Y8565N102 | CL A | 3,654,776 | $9,247,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 356,873 | $8,740,000 | thousands by filing date | |
| FITBIT INC | 33812L102 | CL A | 579,502 | $8,600,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 850,446 | $8,368,000 | thousands by filing date | |
| SOLARCITY CORP | 83416T100 | COM | 406,816 | $7,957,000 | thousands by filing date | |
| SOLARCITY CORP | 83416T100 | COM | 406,000 | $7,941,000 | thousands by filing date | put |
| BELLICUM PHARMACEUTICALS INC | 079481107 | COM | 388,839 | $7,738,000 | thousands by filing date | |
| JPMorgan Chase & Co | 46625H100 | COM | 110,000 | $7,325,000 | thousands by filing date | |
| CHINA ZENIX AUTO INTL LTD | 16951E104 | ADS | 6,074,805 | $5,813,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845PAA6 | NOTE 3.250% 7/0 | 5,000,000 | $5,638,000 | thousands by filing date | principal |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 170,000 | $5,238,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 370,943 | $5,197,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 722,233 | $5,092,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 807,601 | $5,059,000 | thousands by filing date | |
| YY INC | 98426TAB2 | NOTE 2.250 4/0 | 5,000,000 | $4,950,000 | thousands by filing date | principal |
| IMAX CORP | 45245E109 | COM | 169,400 | $4,908,000 | thousands by filing date | |
| NORDIC AMERICAN TANKERS LIMI | G65773106 | COM | 481,120 | $4,864,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 59,002 | $3,999,000 | thousands by filing date | |
| FRONTLINE PLC F | G3682E192 | ORD SHS | 408,341 | $2,930,000 | thousands by filing date | |
| OCERA THERAPEUTICS INC COM | 67552A108 | COM | 932,086 | $2,335,000 | thousands by filing date | |
| TRACON PHARMACEUTICALS INC | 89237H100 | COM | 334,206 | $2,014,000 | thousands by filing date | |
| AUTOHOME INC SP ADS RP CL A | 05278C107 | ADR | 81,400 | $1,974,000 | thousands by filing date | |
| AKARI THERAPEUTICS PLC | 00972G108 | ADR | 263,921 | $1,833,000 | thousands by filing date | |
| PALATIN TECHNOLOGIES INC | 696077403 | COM PAR $ .01 | 4,039,374 | $1,779,000 | thousands by filing date | |
| SPRAGUE RES LP | 849343108 | COM UNIT REP LTD | 39,979 | $844,000 | thousands by filing date | |
| Medgenics Inc New | 58436Q203 | COM NEW | 123,500 | $688,000 | thousands by filing date | |
| FIBROCELL SCIENCE INC | 315721209 | COM NEW | 465,672 | $335,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-16-022293 | this filing | 2016-11-14 | acceptance time not in the bulk data set |